Women's Awareness of and Responses to Messages about Breast Cancer Overdiagnosis and Overtreatment

Rebekah H. Nagler, Erika Franklin Fowler, Sarah E. Gollust

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background: Scientists, clinicians, and other experts aim to maximize the benefits of cancer screening while minimizing its harms. Chief among these harms are overdiagnosis and overtreatment. Although available data suggest that patient awareness of these harms is low, we know little about how patients respond to information about these phenomena. Objectives: Using the case of breast cancer screening, this study assesses women's awareness of and reactions to statements about overdiagnosis and overtreatment. Methods: We draw on data from a 2016 population-based survey of US women aged 35-55 years that oversampled women of lower socioeconomic position (those living at or below 100% of federal poverty level) (N=429). Results: Results showed that women's awareness of overdiagnosis (16.5%) and overtreatment (18.0%) was low, and women under age 40 were least likely to have heard about overdiagnosis. Most women did not evaluate statements about these harms positively: <1 in 4 agreed with and found statements about overdiagnosis and overtreatment to be believable, and even fewer evaluated them as strong arguments to consider in their own mammography decision making. Women with a recent mammogram history were particularly unconvinced by overdiagnosis and overtreatment arguments. Conclusions: A majority of women were unaware of 2 important harms of breast cancer screening: overdiagnosis and overtreatment. Most did not find statements about these harms to be believable and persuasive. Communication interventions, supported by evidence from health communication research, are necessary to improve patient understanding of screening's harms, promote informed decision making, and, in turn, ensure high-value care.

Original languageEnglish (US)
Pages (from-to)879-885
Number of pages7
JournalMedical Care
Volume55
Issue number10
DOIs
StatePublished - Jan 1 2017

Fingerprint

Breast Neoplasms
Early Detection of Cancer
Medical Overuse
Decision Making
Patient Harm
Health Communication
Mammography
Poverty
History
Communication
Research
Population

Keywords

  • breast cancer
  • health communication
  • mammography screening
  • overdiagnosis
  • overtreatment

Cite this

Women's Awareness of and Responses to Messages about Breast Cancer Overdiagnosis and Overtreatment. / Nagler, Rebekah H.; Franklin Fowler, Erika; Gollust, Sarah E.

In: Medical Care, Vol. 55, No. 10, 01.01.2017, p. 879-885.

Research output: Contribution to journalArticle

@article{4ec91108b28f4e3e9bffe2ddebdcf0e2,
title = "Women's Awareness of and Responses to Messages about Breast Cancer Overdiagnosis and Overtreatment",
abstract = "Background: Scientists, clinicians, and other experts aim to maximize the benefits of cancer screening while minimizing its harms. Chief among these harms are overdiagnosis and overtreatment. Although available data suggest that patient awareness of these harms is low, we know little about how patients respond to information about these phenomena. Objectives: Using the case of breast cancer screening, this study assesses women's awareness of and reactions to statements about overdiagnosis and overtreatment. Methods: We draw on data from a 2016 population-based survey of US women aged 35-55 years that oversampled women of lower socioeconomic position (those living at or below 100{\%} of federal poverty level) (N=429). Results: Results showed that women's awareness of overdiagnosis (16.5{\%}) and overtreatment (18.0{\%}) was low, and women under age 40 were least likely to have heard about overdiagnosis. Most women did not evaluate statements about these harms positively: <1 in 4 agreed with and found statements about overdiagnosis and overtreatment to be believable, and even fewer evaluated them as strong arguments to consider in their own mammography decision making. Women with a recent mammogram history were particularly unconvinced by overdiagnosis and overtreatment arguments. Conclusions: A majority of women were unaware of 2 important harms of breast cancer screening: overdiagnosis and overtreatment. Most did not find statements about these harms to be believable and persuasive. Communication interventions, supported by evidence from health communication research, are necessary to improve patient understanding of screening's harms, promote informed decision making, and, in turn, ensure high-value care.",
keywords = "breast cancer, health communication, mammography screening, overdiagnosis, overtreatment",
author = "Nagler, {Rebekah H.} and {Franklin Fowler}, Erika and Gollust, {Sarah E.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1097/MLR.0000000000000798",
language = "English (US)",
volume = "55",
pages = "879--885",
journal = "Medical Care",
issn = "0025-7079",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Women's Awareness of and Responses to Messages about Breast Cancer Overdiagnosis and Overtreatment

AU - Nagler, Rebekah H.

AU - Franklin Fowler, Erika

AU - Gollust, Sarah E.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Background: Scientists, clinicians, and other experts aim to maximize the benefits of cancer screening while minimizing its harms. Chief among these harms are overdiagnosis and overtreatment. Although available data suggest that patient awareness of these harms is low, we know little about how patients respond to information about these phenomena. Objectives: Using the case of breast cancer screening, this study assesses women's awareness of and reactions to statements about overdiagnosis and overtreatment. Methods: We draw on data from a 2016 population-based survey of US women aged 35-55 years that oversampled women of lower socioeconomic position (those living at or below 100% of federal poverty level) (N=429). Results: Results showed that women's awareness of overdiagnosis (16.5%) and overtreatment (18.0%) was low, and women under age 40 were least likely to have heard about overdiagnosis. Most women did not evaluate statements about these harms positively: <1 in 4 agreed with and found statements about overdiagnosis and overtreatment to be believable, and even fewer evaluated them as strong arguments to consider in their own mammography decision making. Women with a recent mammogram history were particularly unconvinced by overdiagnosis and overtreatment arguments. Conclusions: A majority of women were unaware of 2 important harms of breast cancer screening: overdiagnosis and overtreatment. Most did not find statements about these harms to be believable and persuasive. Communication interventions, supported by evidence from health communication research, are necessary to improve patient understanding of screening's harms, promote informed decision making, and, in turn, ensure high-value care.

AB - Background: Scientists, clinicians, and other experts aim to maximize the benefits of cancer screening while minimizing its harms. Chief among these harms are overdiagnosis and overtreatment. Although available data suggest that patient awareness of these harms is low, we know little about how patients respond to information about these phenomena. Objectives: Using the case of breast cancer screening, this study assesses women's awareness of and reactions to statements about overdiagnosis and overtreatment. Methods: We draw on data from a 2016 population-based survey of US women aged 35-55 years that oversampled women of lower socioeconomic position (those living at or below 100% of federal poverty level) (N=429). Results: Results showed that women's awareness of overdiagnosis (16.5%) and overtreatment (18.0%) was low, and women under age 40 were least likely to have heard about overdiagnosis. Most women did not evaluate statements about these harms positively: <1 in 4 agreed with and found statements about overdiagnosis and overtreatment to be believable, and even fewer evaluated them as strong arguments to consider in their own mammography decision making. Women with a recent mammogram history were particularly unconvinced by overdiagnosis and overtreatment arguments. Conclusions: A majority of women were unaware of 2 important harms of breast cancer screening: overdiagnosis and overtreatment. Most did not find statements about these harms to be believable and persuasive. Communication interventions, supported by evidence from health communication research, are necessary to improve patient understanding of screening's harms, promote informed decision making, and, in turn, ensure high-value care.

KW - breast cancer

KW - health communication

KW - mammography screening

KW - overdiagnosis

KW - overtreatment

UR - http://www.scopus.com/inward/record.url?scp=85030611110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030611110&partnerID=8YFLogxK

U2 - 10.1097/MLR.0000000000000798

DO - 10.1097/MLR.0000000000000798

M3 - Article

VL - 55

SP - 879

EP - 885

JO - Medical Care

JF - Medical Care

SN - 0025-7079

IS - 10

ER -